James Thomas, MD
- Staff Cardiologist
- Miller Family Heart and Vascular Institute
E. Murat Tuzcu, MD
- Vice Chairman
- Robert and Suzanne Tomsich Department of Cardiovascular Medicine
Heart valve disease occurs when one or more of the heart valves do not work correctly because of valvular stenosis or valvular insufficiency. These conditions cause the heart to pump harder to circulate the right amount of blood through the body. Left untreated, heart valve disease can reduce a person’s quality of life and become life-threatening. There are non-surgical ways of treating valve disease called percutaneous interventions for those who cannot tolerate surgery or are not in need of surgery. Take this opportunity to learn more about valve disease, including diagnosis and non-surgical treatments, and have your questions answered by cardiologists James Thomas, MD and E. Murat Tuzcu, MD.
James Thomas, MD, is a staff cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is Lead Scientist for Ultrasound to the National Aeronautics and Space Administration (NASA). Dr. Thomas is board-certified as a Diplomate in the National Board of Medical Examiners, the American Board of Internal Medicine, and the Cardiovascular Subspecialty Board. His specialty interest is echocardiography. Dr. Thomas has published more than 500 peer-viewed articles in professional journals, written seven books and contributed more than 100 book chapters to professional medical textbooks. He has published more than 700 abstracts.
E. Murat Tuzcu, MD, is a Professor of Medicine, Vice Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, and a Staff Physician in the Section of Interventional Cardiology in the Sydell and Arnold Heart & Vascular Institute. Dr. Tuzcu's clinical interests cover a wide range of interventional cardiology patients. In addition to percutaneous treatment of coronary artery disease, his expertise includes catheter-based treatment of valvular heart disease (Transcatheter aortic valve replacement - TAVR), and adult congenital heart defects. He is an internationally recognized expert in the emerging field of percutaneous valve repair and replacement.
This Health Chat will open on
Sunday, May 18, 2014
to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.